| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 269 |
| 1 | CLOZAPINE | 88 |
| 2 | OMEPRAZOLE MAGNESIUM | 87 |
| 3 | OMEPRAZOLE | 76 |
| 4 | PREDNISONE | 66 |
| 5 | INFLIXIMAB | 65 |
| 6 | METHOTREXATE SODIUM | 61 |
| 7 | FUROSEMIDE | 59 |
| 8 | ASPIRIN | 58 |
| 9 | ASPIRIN 325 MG | 57 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 1 | 0.0137 |
| 1 | GLYCERINE | 4 | 0.0123 |
| 2 | CEFOTETAN DISODIUM | 1 | 0.0089 |
| 3 | CEFOTETAN | 1 | 0.0075 |
| 4 | ALUMINUM HYDROXIDE GEL | 1 | 0.0071 |
| 5 | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | 1 | 0.0067 |
| 6 | THROMBIN HUMAN AND FIBRINOGEN | 2 | 0.0060 |
| 7 | ORPHENADRINE CITRATE | 3 | 0.0048 |
| 8 | NEOSTIGMINE METHYLSULFATE | 2 | 0.0047 |
| 9 | CETYLPYRIDINIUM CHLORIDE | 3 | 0.0046 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 176 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 133 |
| 2 | Atypical Antipsychotic [EPC] | 132 |
| 3 | Benzodiazepine [EPC] | 130 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 110 |
| 5 | Proton Pump Inhibitor [EPC] | 109 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 86 |
| 7 | Osmotic Laxative [EPC] | 69 |
| 8 | Platinum-based Drug [EPC] | 67 |
| 9 | Interleukin-23 Antagonist [EPC] | 66 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 2 | 0.0060 |
| 1 | Vitamin K [EPC] | 12 | 0.0028 |
| 2 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0016 |
| 3 | GLP-2 Analog [EPC] | 21 | 0.0016 |
| 4 | Interferon gamma [EPC] | 2 | 0.0014 |
| 5 | Benzodiazepine Antagonist [EPC] | 1 | 0.0012 |
| 6 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 8 | 0.0011 |
| 7 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 8 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0008 |
| 9 | Interleukin-2 Receptor Blocking Antibody [EPC] | 9 | 0.0008 |